Biowatch, are these kinds of letters atypical in DNDN's situation, or are do they occassionally happen for drug approvals? When someone coined the term "battleground" stock for DNDN, they really meant it. I look forward to the evolution of this immunotherapy field one step at a time. ;)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.